Advertiser / Brand · vs · Agency & Consultancy
CME Group vs Melius Research
Structured technology and market comparison · 2026
Direct Feature Comparison
CME Group · vs · Melius ResearchPublic derivatives exchange and clearing operator for institutional markets.
Independent equity research and analytics for institutional clients.
Analyze all overlapping signals and tech stacks for CME Group and Melius Research
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between CME Group and Melius Research?
When comparing CME Group and Melius Research, both platforms operate within the Other / Non-Digital Advertising Relevant ecosystem. CME Group is positioned as Public derivatives exchange and clearing operator for institutional markets, whereas Melius Research focuses on Independent equity research and analytics for institutional clients. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to CME Group and Melius Research?
When evaluating CME Group and Melius Research, enterprise buyers also consider other platforms in Other / Non-Digital Advertising Relevant. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of CME Group and Melius Research compare?
CME Group is headquartered in US (founding year unrecorded) with 1,001–5,000 employees. Melius Research is based in US (founded in 2017) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: CME Group vs Melius Research
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
CME Group
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for CME Group (2026-10-21)
On October 21, 2026, CME Group Inc. furnished a Form 8-K under Item 2.02 to announce its financial results for the third quarter ended September 30, 2026, via an attached press release (Exhibit 99.1). The filing notes the inclusion of non-GAAP financial measures—including non-GAAP revenues, expenses, operating income, net income, and earnings per share—alongside direct reconciliations to GAAP metrics pursuant to Regulation G. The filing was executed by Lynne Fitzpatrick, Senior Managing Director, President and Chief Financial Officer.
- CME Group furnished its financial results for the quarter ended September 30, 2026, via press release Exhibit 99.1 on October 21, 2026.
- The disclosure incorporates non-GAAP financial metrics covering revenues, operating expenses, operating income, net income, and EPS alongside GAAP reconciliations under Regulation G.
- The filing was formally authorized and executed by Lynne Fitzpatrick in her capacity as Senior Managing Director, President, and Chief Financial Officer.
- ·SEC APIfinancials
8-K Financial Filing Analysis for CME Group (2026-08-11)
On August 11, 2026, CME Group Inc. filed a Form 8-K under Item 7.01 (Regulation FD Disclosure) announcing pricing changes communicated to clients via Special Executive Report No. 9799. The updated fee schedule and related notices have been made available on the company's corporate website. As a standard Item 7.01 disclosure, the filing provides notice of fee adjustments across its derivatives exchange and clearing operations without including detailed financial tables or immediate pro-forma financial updates.
- CME Group announced client pricing adjustments via Special Executive Report No. 9799 on August 11, 2026.
- The disclosure was furnished under Item 7.01 (Regulation FD) and signed by Senior Managing Director, President and CFO Lynne Fitzpatrick.
- Detailed fee schedules and notice documentation were published directly on CME Group's corporate website.
- ·CNBC InvestingMacro Economy
Fed Rate Hike Seemed Certain After August Inflation Data
The article discusses the market outlook for the week of September 14-18, 2026, following the release of August CPI data showing 3.4% annual inflation, which is well above the Fed's 2% target. Federal Reserve Chairman Kevin Warsh is expected to deliver a quarter-point rate hike at the upcoming FOMC meeting to maintain credibility. Oil prices surged above $100 per barrel due to U.S.-Iran hostilities, driving up yields, with the 10-year Treasury yield near 5%. Investor sentiment is mixed, with some seeing potential relief if inflation improves or Middle East tensions resolve, while others fear further hikes. Fed funds futures indicate a nearly 50% chance of rates reaching 4%-4.25% by December, implying two more hikes. The article also includes a calendar of upcoming economic data releases.
- August CPI showed 3.4% annual inflation, above the Fed's 2% target.
- Fed Chairman Kevin Warsh is expected to deliver a quarter-point rate hike at the September FOMC meeting.
- Oil prices surged above $100 per barrel due to U.S.-Iran hostilities.
Melius Research
Recent Signals
- ·CNBC TechnologyEarnings Report
Apple's iPhone Duo Shows Strong Preorder Demand, Boosts Growth Outlook
Apple's first foldable device, the iPhone Duo, is showing extremely strong early demand following its preorder launch, validating Jim Cramer's bullish prediction. Morgan Stanley reports record global preorder lead times, with the earliest delivery dates for some models more than three months out, the longest in the last 10 years. This demand is seen as a key catalyst for Apple's growth, with Melius Research estimating over 15 million units could be sold in fiscal 2027, generating roughly $40 billion in revenue. The analyst notes that the strong Duo demand may also help iPhone 18 sales. Apple's stock has surpassed a $5 trillion market cap for the first time, and the company is expected to report earnings on November 2.
- Apple's iPhone Duo preorders started Friday, with strong demand indicated by long shipping delays.
- Morgan Stanley reported the global 14-week average preorder lead time is a record, the longest of any iPhone model in 10 years.
- Melius Research estimates Apple could sell at least 15 million Duo units in fiscal 2027, generating about $40 billion in revenue.
- ·CNBC InvestingFinancials
Intel could hit $200 per share in two years, says Melius analyst
Melius Research analyst Ben Reitzes has set a buy rating on Intel with a $165 price target, implying about 70% upside from the previous close, but sees the stock reaching as high as $200 per share within two years. Reitzes bases his bullish outlook on potential foundry agreements with Apple, Tesla, and another hyperscaler, and strong server CPU pricing and AI PC mix that could drive product earnings above $4. He also notes a Reuters report that Intel is considering a deal to help SK Hynix manufacture memory chips in the U.S., potentially leasing part of its Ohio facility. Intel shares have gained roughly 300% over the past 12 months, and the stock was up more than 4% on the day. The analyst's view contrasts with consensus, as only 15 of 50 analysts rate it a buy.
- Melius Research has a buy rating on Intel with a $165 price target, implying ~70% upside.
- Analyst Ben Reitzes sees Intel trading as high as $200 per share in the next two years.
- Intel could rally on foundry agreements with Apple, Tesla, and another hyperscaler, per analyst.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners CME Group and Melius Research share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks